M'Hammed Aguennouz
M'Hammed Aguennouz
Verified email at unime.it
Cited by
Cited by
miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors
A Conti, MH Aguennouz, D La Torre, C Tomasello, S Cardali, FF Angileri, ...
Journal of neuro-oncology 93 (3), 325-332, 2009
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy
MC Monici, M Aguennouz, A Mazzeo, C Messina, G Vita
Neurology 60 (6), 993-997, 2003
Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients
M Guglieri, F Magri, MG D'Angelo, A Prelle, L Morandi, C Rodolico, ...
Human mutation 29 (2), 258-266, 2008
Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice
S Messina, A Bitto, M Aguennouz, L Minutoli, MC Monici, D Altavilla, ...
Experimental neurology 198 (1), 234-241, 2006
Lipid peroxidation inhibition blunts nuclear factor-κB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice
S Messina, D Altavilla, M Aguennouz, P Seminara, L Minutoli, MC Monici, ...
The American journal of pathology 168 (3), 918-926, 2006
Nuclear factor‐κB activation and differential expression of survivin and Bcl‐2 in human grade 2–4 astrocytomas
FF Angileri, MH Aguennouz, A Conti, D La Torre, S Cardali, R Crupi, ...
Cancer 112 (10), 2258-2266, 2008
VEGF overexpression via adeno‐associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice
S Messina, A Mazzeo, A Bitto, M Aguennouz, A Migliorato, ...
The FASEB journal 21 (13), 3737-3746, 2007
Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease
P Aragona, MH Aguennouz, L Rania, E Postorino, MS Sommario, ...
Ophthalmology 122 (1), 62-71, 2015
Activation of NF-kB pathway in Duchenne muscular dystrophy: relation to age
S Messina, GL Vita, M Aguennouz, M Sframeli, S Romeo, C Rodolico, ...
Acta myologica 30 (1), 16, 2011
Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies
R Cagliani, F Magri, A Toscano, L Merlini, F Fortunato, C Lamperti, ...
Human mutation 26 (3), 283-283, 2005
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone
S Messina, A Bitto, M Aguennouz, A Mazzeo, A Migliorato, F Polito, ...
Experimental neurology 220 (2), 349-358, 2009
Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency
S Corti, A Bordoni, D Ronchi, O Musumeci, M Aguennouz, A Toscano, ...
Journal of the neurological sciences 266 (1-2), 97-103, 2008
Limb-girdle myasthenia: clinical, electrophysiological and morphological features in familial and autoimmune cases
C Rodolico, A Toscano, M Autunno, S Messina, C Nicolosi, M Aguennouz, ...
Neuromuscular Disorders 12 (10), 964-969, 2002
RAGE‐NF‐κB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy
V Macaione, M Aguennouz, C Rodolico, A Mazzeo, A Patti, E Cannistraci, ...
Acta Neurologica Scandinavica 115 (2), 115-121, 2007
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII)
O Musumeci, C Bruno, T Mongini, C Rodolico, M Aguennouz, E Barca, ...
Neuromuscular Disorders 22 (4), 325-330, 2012
Oxidative stress in myotonic dystrophy type 1
A Toscano, S Messina, GM Campo, RD Leo, O Musumeci, C Rodolico, ...
Free radical research 39 (7), 771-776, 2005
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene
O Musumeci, C Rodolico, I Nishino, G Di Guardo, A Migliorato, ...
Neuromuscular Disorders 15 (6), 409-411, 2005
Expression of the tumor necrosis factor receptor—associated factors 1 and 2 and regulation of the nuclear factor—kB antiapoptotic activity in human gliomas
A Conti, MH Aguennouz, D La Torre, S Cardali, FF Angileri, C Buemi, ...
Journal of neurosurgery 103 (5), 873-881, 2005
Mutations in the neuronal vesicular SNARE VAMP2 affect synaptic membrane fusion and impair human neurodevelopment
V Salpietro, NT Malintan, I Llano-Rivas, CG Spaeth, S Efthymiou, ...
The American Journal of Human Genetics 104 (4), 721-730, 2019
Role of inflammation and oxidative stress mediators in gliomas
A Conti, C Gul, D La Torre, C Tomasello, FF Angileri, MH Aguennouz
Cancers 2 (2), 693-712, 2010
The system can't perform the operation now. Try again later.
Articles 1–20